Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway KJ Kurppa, Y Liu, C To, T Zhang, M Fan, A Vajdi, EH Knelson, Y Xie, ... Cancer cell 37 (1), 104-122. e12, 2020 | 337 | 2020 |
Integrative analyses of single-cell transcriptome and regulome using MAESTRO C Wang, D Sun, X Huang, C Wan, Z Li, Y Han, Q Qin, J Fan, X Qiu, Y Xie, ... Genome biology 21, 1-28, 2020 | 134 | 2020 |
Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade SS Gu, W Zhang, X Wang, P Jiang, N Traugh, Z Li, C Meyer, B Stewig, ... Cancer discovery 11 (6), 1524-1541, 2021 | 122 | 2021 |
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets X Qiu, N Boufaied, T Hallal, A Feit, A de Polo, AM Luoma, W Alahmadi, ... Nature communications 13 (1), 2559, 2022 | 80 | 2022 |
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer P Cejas, Y Xie, A Font-Tello, K Lim, S Syamala, X Qiu, AK Tewari, N Shah, ... Nature communications 12 (1), 5775, 2021 | 80 | 2021 |
Juvenile hormone activates the transcription of cell-division-cycle 6 (Cdc6) for polyploidy-dependent insect vitellogenesis and oogenesis Z Wu, W Guo, Y Xie, S Zhou Journal of Biological Chemistry 291 (10), 5418-5427, 2016 | 69 | 2016 |
Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence Z Wu, J Zhou, X Zhang, Z Zhang, Y Xie, J Liu, ZV Ho, A Panda, X Qiu, ... Nature genetics 53 (6), 881-894, 2021 | 54 | 2021 |
Hsa_circ_0001859 regulates ATF2 expression by functioning as an miR‐204/211 sponge in human rheumatoid arthritis B Li, N Li, L Zhang, K Li, Y Xie, M Xue, Z Zheng Journal of immunology research 2018 (1), 9412387, 2018 | 54 | 2018 |
Chromatin accessibility promotes hematopoietic and leukemia stem cell activity L Cabal-Hierro, P van Galen, MA Prado, KJ Higby, K Togami, CT Mowery, ... Nature communications 11 (1), 1406, 2020 | 51 | 2020 |
TRPS1 is a lineage-specific transcriptional dependency in breast cancer RM Witwicki, MB Ekram, X Qiu, M Janiszewska, S Shu, M Kwon, A Trinh, ... Cell reports 25 (5), 1255-1267. e5, 2018 | 50 | 2018 |
Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells RE Tay, O Olawoyin, P Cejas, Y Xie, CA Meyer, Y Ito, QY Weng, ... Journal of Experimental Medicine 217 (7), e20191453, 2020 | 44 | 2020 |
An enhancer-driven stem cell–like program mediated by SOX9 blocks intestinal differentiation in colorectal cancer X Liang, GN Duronio, Y Yang, P Bala, P Hebbar, S Spisak, P Sahgal, ... Gastroenterology 162 (1), 209-222, 2022 | 38 | 2022 |
Androgen receptor is a non-canonical inhibitor of wild-type and mutant estrogen receptors in hormone receptor-positive breast cancers S Ponnusamy, S Asemota, LS Schwartzberg, F Guestini, KM McNamara, ... Iscience 21, 341-358, 2019 | 29 | 2019 |
CoBRA: containerized bioinformatics workflow for reproducible ChIP/ATAC-seq analysis X Qiu, AS Feit, A Feiglin, Y Xie, N Kesten, L Taing, J Perkins, S Gu, Y Li, ... Genomics, Proteomics and Bioinformatics 19 (4), 652-661, 2021 | 26 | 2021 |
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes EJ Schaefer, HC Wang, HQ Karp, CA Meyer, P Cejas, MD Gearhart, ... Blood cancer discovery 3 (2), 116-135, 2022 | 24 | 2022 |
FiTAc-seq: fixed-tissue ChIP-seq for H3K27ac profiling and super-enhancer analysis of FFPE tissues A Font-Tello, N Kesten, Y Xie, L Taing, D Varešlija, LS Young, AA Hamid, ... Nature Protocols, 1-16, 2020 | 23 | 2020 |
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance Y Li, X Qiu, X Wang, H Liu, RC Geck, AK Tewari, T Xiao, A Font-Tello, ... Nature cell biology 23 (11), 1187-1198, 2021 | 22 | 2021 |
Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma J Zhou, Z Wu, Z Zhang, L Goss, J McFarland, A Nagaraja, Y Xie, S Gu, ... Gut 71 (4), 665-675, 2022 | 17 | 2022 |
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer L Duplaquet, Y Li, MA Booker, Y Xie, SN Olsen, RA Patel, D Hong, ... Nature Cell Biology 25 (9), 1346-1358, 2023 | 16 | 2023 |
YAP1 and PRDM14 converge to promote cell survival and tumorigenesis M Kim, SH Ly, Y Xie, GN Duronio, D Ford-Roshon, JH Hwang, R Sulahian, ... Developmental cell 57 (2), 212-227. e8, 2022 | 16 | 2022 |